Funding

The Chandra Lab is supported by grants from the National Institutes of Health (NIH), private foundations, and professional organizations. Our research has been continuously NIH-funded for over a decade, and our grant portfolio is expanding. 

Current Funding

1. R01HL153400:  Role of FBXO24 mediated ubiquitination of FoxP1 protein in the pathogenesis and treatment of COPD. 

2. R13HL176036: Pittsburgh International Lung Conference: From Smog to Social Equity: How the Exposome Shapes Our Respiratory Health.

3. American Lung Association: Developing Lithium as a Disease Modifying Therapy for Emphysema Using a Precision Medicine Approach.

4. Breath PA Foundation: Determining the acute physiologic and inflammatory effects of regular use of real-world, flavored vaping products.

Upcoming funding

1. NHLBI R01HL179364: Council review completed, NOA pending. 

Prior Funding

1. Pittsburgh Foundation: Use of Electronic Cigarettes as a Novel Risk Factor for Emphysema in Young Individuals.

2. K23HL126912: Autoimmunity as a Mechanism for Atherosclerosis in COPD.

3. Samuel and Emma Winters Foundation: The Ubiquitin Proteasome System as a Novel Regulator of Atherosclerosis in COPD

4. Bernie Pennock Outstanding Young Investigator Award.